Age-related Macular Degeneration // Barbara Blodi // Clinical Trials // Past // Feb 14 2017
A Phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration.
Sponsor: F. Hoffman-La Roche Ltd